Congenital toxoplasmosis after adalimumab treatment before pregnancy
Published in
Journal of obstetrics and gynaecology research, vol. 47, no. 11, p. 4055-4059Publication date
2021-11First online date
2021-08-11Abstract
Keywords
- Congenital toxoplasmosis
- Immunosuppressive therapy
- Infectious diseases
- Pregnancy
- Prenatal diagnosis
- Adalimumab / adverse effects
- Amniocentesis
- Female
- Humans
- Pregnancy
- Pregnancy Complications, Infectious
- Toxoplasmosis / diagnosis
- Toxoplasmosis / drug therapy
- Toxoplasmosis, Congenital / diagnosis
- Toxoplasmosis, Congenital / drug therapy
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
KRULL, Eloise et al. Congenital toxoplasmosis after adalimumab treatment before pregnancy. In: Journal of obstetrics and gynaecology research, 2021, vol. 47, n° 11, p. 4055–4059. doi: 10.1111/jog.14973
Main files (1)
Article (Published version)
Identifiers
- PID : unige:167124
- DOI : 10.1111/jog.14973
- PMID : 34382299
- PMCID : PMC9292430
